Table 3.
Comparison of TLR2 and inflammatory factor expression levels in serum of control, familial hypertension, and familial hypertension combined with hyperlipemia groups.
| Indicator | Control group | Familial hypertension | Familial hypertension combined with hyperlipemia | F | P |
|---|---|---|---|---|---|
| TLR2 | 41.26 ± 6.80 | 58.89 ± 11.33∗∗∗ | 63.39 ± 9.95∗∗∗ | 31.52 | <0.001 |
| IL-1β | 4.31 ± 0.86 | 24.74 ± 5.56∗∗∗ | 32.00 ± 7.57∗∗∗††† | 153.10 | <0.001 |
| IL-6 | 8.14 ± 3.53 | 35.01 ± 10.51∗∗∗ | 37.92 ± 16.88∗∗∗ | 45.46 | <0.001 |
| TNF-ɑ | 54.75 ± 18.01 | 190.70 ± 56.51∗∗∗ | 262.8 ± 63.50∗∗∗††† | 94.29 | <0.001 |
| CCL2 | 153.60 ± 18.63 | 149.80 ± 19.99 | 151.40 ± 19.87 | 0.22 | 0.805 |
∗∗∗ Familial hypertension group versus control group, P < 0.001; †††familial hypertension compared with hyperlipemia versus control group, P < 0.001.